BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37843918)

  • 1. AS1411aptamer conjugated liposomes for targeted delivery of arsenic trioxide in mouse xenograft model of melanoma cancer.
    Shariat Razavi F; Kouchak M; Sistani Karampour N; Mahdavinia M; Nazari Khorasgani Z; Rezaie A; Rahbar N
    J Liposome Res; 2024 Jun; 34(2):288-302. PubMed ID: 37843918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel and efficient method for loading aptamer-conjugated liposomes with arsenic trioxide for targeting cancer cells.
    Mirveis Z; Kouchak M; Mahdavinia M; Rahbar N
    J Liposome Res; 2022 Sep; 32(3):276-283. PubMed ID: 34918592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological studies of an ICG-tagged aptamer as drug delivery system for malignant melanoma.
    Lopes-Nunes J; Lifante J; Shen Y; Ximendes EC; Jaque D; Iglesias-de la Cruz MC; Cruz C
    Eur J Pharm Biopharm; 2020 Sep; 154():228-235. PubMed ID: 32707287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model.
    Zavvar T; Babaei M; Abnous K; Taghdisi SM; Nekooei S; Ramezani M; Alibolandi M
    Int J Pharm; 2020 Mar; 578():119091. PubMed ID: 32007591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies.
    Zhang YF; Wang JC; Bian DY; Zhang X; Zhang Q
    Eur J Pharm Biopharm; 2010 Mar; 74(3):467-73. PubMed ID: 20064608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
    Song X; Wang J; Xu Y; Shao H; Gu J
    Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.
    Yu KF; Zhang WQ; Luo LM; Song P; Li D; Du R; Ren W; Huang D; Lu WL; Zhang X; Zhang Q
    Int J Nanomedicine; 2013; 8():2473-85. PubMed ID: 23885174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
    Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
    J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-mediated synthesis of multifunctional nano-hydroxyapatite for active tumour bioimaging and treatment.
    Zhang W; Zhou R; Yang Y; Peng S; Xiao D; Kong T; Cai X; Zhu B
    Cell Prolif; 2021 Sep; 54(9):e13105. PubMed ID: 34382270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
    Korani M; Nikoofal-Sahlabadi S; Nikpoor AR; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
    Anticancer Agents Med Chem; 2020; 20(6):700-708. PubMed ID: 31893998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
    Du R; Zhong T; Zhang WQ; Song P; Song WD; Zhao Y; Wang C; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2014; 9():3091-105. PubMed ID: 25028548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy and cardioprotection of nucleolin-targeted doxorubicin-loaded ultrasound nanobubbles in treating triple-negative breast cancer.
    Fang K; Wang L; Huang H; Dong S; Guo Y
    Nanotechnology; 2021 Mar; 32(24):. PubMed ID: 33690196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome-Coated Arsenic-Manganese Complex for Magnetic Resonance Imaging-Guided Synergistic Therapy Against Carcinoma.
    Jin Z; Yi X; Yang J; Zhou M; Wu P; Yan G
    Int J Nanomedicine; 2021; 16():3775-3788. PubMed ID: 34113100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency.
    Zhang T; Zhou S; Hu L; Peng B; Liu Y; Luo X; Liu X; Song Y; Deng Y
    Drug Deliv Transl Res; 2018 Jun; 8(3):602-616. PubMed ID: 29536348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
    Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H
    Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study.
    Akhtar A; Wang SX; Ghali L; Bell C; Wen X
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopep-2-modified calcium arsenite-loaded liposomes for targeted and pH-responsive delivery for anti-glioma therapy.
    Xu H; Li C; Wei Y; Zheng H; Zheng H; Wang B; Piao JG; Li F
    Biochem Biophys Res Commun; 2021 Apr; 551():14-20. PubMed ID: 33714754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
    Wang F; Chen L; Zhang R; Chen Z; Zhu L
    J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Tumor Efficacy of Pyrvinium Pamoate Nanoliposomes in an Experimental Model of Melanoma.
    Hatamipour M; Jaafari MR; Zangui M; Shakour N; Sahebkar A
    Anticancer Agents Med Chem; 2021; 21(17):2379-2384. PubMed ID: 33596812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.
    Baneshi M; Dadfarnia S; Shabani AMH; Sabbagh SK; Haghgoo S; Bardania H
    Int J Pharm; 2019 Jun; 564():145-152. PubMed ID: 30978484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.